Glenmark Pharmaceuticals informs about disclosure

06 Aug 2021 Evaluate

Further to its intimations dated April 16, 2021, July 20, 2021 and August 3, 2021, on the listing of equity shares of Glenmark Life Sciences, Glenmark Pharmaceuticals has informed that the equity shares of the wholly owned subsidiary of the Company, Glenmark Life Sciences, were admitted for listing by BSE and National Stock Exchange of India with effect from August 6, 2021.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1992.70 -8.35 (-0.42%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×